HRT Financial’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
165,106
+132,004
+399% +$11.2M 0.02% 735
2026
Q1
$3.29M Buy
+33,102
New +$4.32M 0.01% 1258
2025
Q4
– Sell
-4,922
Closed -$552K – 4036
2025
Q3
$552K Buy
+4,922
New +$576K ﹤0.01% 1834
2025
Q2
– Sell
-11,469
Closed -$771K – 3517
2025
Q1
$771K Buy
+11,469
New +$789K ﹤0.01% 1250
2024
Q2
– Sell
-8,559
Closed -$632K – 3105
2024
Q1
$632K Buy
+8,559
New +$705K ﹤0.01% 1137
2023
Q4
– Sell
-5,438
Closed -$297K – 3081
2023
Q3
$297K Sell
5,438
-4,080
-43% -$294K ﹤0.01% 1662
2023
Q2
$799K Sell
9,518
-13,659
-59% -$1.05M 0.01% 1084
2023
Q1
$1.75M Buy
23,177
+17,060
+279% +$1.18M 0.02% 662
2022
Q4
$377K Buy
+6,117
New +$325K 0.01% 1604
2021
Q3
– Sell
-8,741
Closed -$290K – 3756
2021
Q2
$290K Buy
+8,741
New +$242K ﹤0.01% 2159

Other funds holding TMDX

HRT Financial's TMDX Position: Q2 2026 in Review

HRT Financial increased its Transmedics (TMDX) stake by 399% in Q2 2026, buying an estimated $11.2M and bringing the position to 165,106 shares worth $11M. The position accounts for 0.02% of the portfolio, ranked #735.

HRT Financial first reported a position in TMDX in Q2 2021 and has held it in 10 quarters since. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • HRT Financial held 165,106 shares of Transmedics worth $11M as of Q2 2026.
  • HRT Financial bought 132,004 Transmedics shares in Q2 2026, an estimated $11.2M.
  • Transmedics made up 0.02% of HRT Financial's portfolio in Q2 2026, its #735 holding.
  • HRT Financial first reported a position in Transmedics in Q2 2021 and has held it in 10 quarters since.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.